2026 Q2 -tulosraportti
Äänite tulossa
2 päivää sitten
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 4.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 26.8. | ||
2026 Q1 -tulosraportti 27.5. | ||
2025 Q4 -tulosraportti 27.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 |
Asiakkaat katsoivat myös
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
16 min sitten · MuokattuThe company valuation slumped at levels last seen in 2024 and meanwhile people still can’t admit they were so incredibly delusional that they actually believed some life saving deal was just around the corner. Hilarious. Face facts, I was correct ever since the initial down trend from 11SEK. The burn rate is far too high to be headed anywhere else than refinancing on dilutive terms or a straight up FPO. Furthermore no data, not even the latest EAP data have concrete signs of efficacy so that big licensing deal/exit everyone was convinced was going to happen isn’t anywhere close to being closed on. Hyperoptimists 0 - Realists 1
·2 päivää sittenNot easy to interpret today's report? But more money will be needed in 6 months - again!? After just received 60 million!? Burn rate of 10 million a month!! Hmmm…. One probably needs to ponder a bit here.Acceleron had a market cap of approximately $2bn before the phase 2 results, just over ten times higher than Cereno has after its phase 2a. For those who believe that Cereno can deliver placebo-controlled results in line with Acceleron's PULSAR, Cereno is a bargain. Even though I have some hope for the therapy itself, I have long since lost confidence in Cereno as a company. They have promised much but delivered little. The expected positive announcements over the past year have, without exception, been disappointments. Possibly, possibly they can turn it around, but before anything positive comes, I expect a continued downward trend. If I invest, I will do so when more clarity is available regarding the ongoing phase 2 study.
·19.8.I've been well over 100% up, now I'm under 10%. I'm heavily invested, of course regretting not selling at the top. Now the question is? Should one sell or wait until one is left holding the bag?
I sold a few months ago, only have some listening posts left. I have and had faith in the company, i.e. the product. But I've been involved since the dawn of time, I've been through the infamous spiral bank financing as well as share issues and not least when the financial supervisory authority made its entry. I eventually had a low average cost and a good number of shares, i.e. about 400k. Started selling at just over 6.5 kroner. When the sale was completed, I saw that the price was pulled down below 5, Myrild probably also sold some. So the idea was to rather chase after than lose most of it. The chase hasn't started yet. But I've taken note of what Sten has said, keep your shares, we have many stakeholders etc. Strange that this didn't affect the share price, was the fluidda study difficult or. I feel that critical questions have been shot down all the way, Sten has almost promised a deal this year, is it by the end of 2026 or from the time it was said, I hope for a deal, but I think the deal will be an insanely bad share issue. But I hope I'm wrong, after all, they have traveled the globe many times in recent years, and all meetings are fully booked but it didn't show in the share price, so I think one should also be critical and for example ask why Myrild didn't show up last time.
13.8.Julkaisu on poistettu.Data analysis and type of results 2028. What does the financing look like for this global study?? one might wonder?? 💭🤔
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2026 Q2 -tulosraportti
Äänite tulossa
2 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- 16 min sitten · MuokattuThe company valuation slumped at levels last seen in 2024 and meanwhile people still can’t admit they were so incredibly delusional that they actually believed some life saving deal was just around the corner. Hilarious. Face facts, I was correct ever since the initial down trend from 11SEK. The burn rate is far too high to be headed anywhere else than refinancing on dilutive terms or a straight up FPO. Furthermore no data, not even the latest EAP data have concrete signs of efficacy so that big licensing deal/exit everyone was convinced was going to happen isn’t anywhere close to being closed on. Hyperoptimists 0 - Realists 1
- ·2 päivää sittenNot easy to interpret today's report? But more money will be needed in 6 months - again!? After just received 60 million!? Burn rate of 10 million a month!! Hmmm…. One probably needs to ponder a bit here.Acceleron had a market cap of approximately $2bn before the phase 2 results, just over ten times higher than Cereno has after its phase 2a. For those who believe that Cereno can deliver placebo-controlled results in line with Acceleron's PULSAR, Cereno is a bargain. Even though I have some hope for the therapy itself, I have long since lost confidence in Cereno as a company. They have promised much but delivered little. The expected positive announcements over the past year have, without exception, been disappointments. Possibly, possibly they can turn it around, but before anything positive comes, I expect a continued downward trend. If I invest, I will do so when more clarity is available regarding the ongoing phase 2 study.
- ·19.8.I've been well over 100% up, now I'm under 10%. I'm heavily invested, of course regretting not selling at the top. Now the question is? Should one sell or wait until one is left holding the bag?I sold a few months ago, only have some listening posts left. I have and had faith in the company, i.e. the product. But I've been involved since the dawn of time, I've been through the infamous spiral bank financing as well as share issues and not least when the financial supervisory authority made its entry. I eventually had a low average cost and a good number of shares, i.e. about 400k. Started selling at just over 6.5 kroner. When the sale was completed, I saw that the price was pulled down below 5, Myrild probably also sold some. So the idea was to rather chase after than lose most of it. The chase hasn't started yet. But I've taken note of what Sten has said, keep your shares, we have many stakeholders etc. Strange that this didn't affect the share price, was the fluidda study difficult or. I feel that critical questions have been shot down all the way, Sten has almost promised a deal this year, is it by the end of 2026 or from the time it was said, I hope for a deal, but I think the deal will be an insanely bad share issue. But I hope I'm wrong, after all, they have traveled the globe many times in recent years, and all meetings are fully booked but it didn't show in the share price, so I think one should also be critical and for example ask why Myrild didn't show up last time.
- 13.8.Julkaisu on poistettu.Data analysis and type of results 2028. What does the financing look like for this global study?? one might wonder?? 💭🤔
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 4.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 26.8. | ||
2026 Q1 -tulosraportti 27.5. | ||
2025 Q4 -tulosraportti 27.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 |
2026 Q2 -tulosraportti
Äänite tulossa
2 päivää sitten
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr| Seuraava tapahtuma | |
|---|---|
2026 Q3 -tulosraportti 4.11. |
| Menneet tapahtumat | ||
|---|---|---|
2026 Q2 -tulosraportti 26.8. | ||
2026 Q1 -tulosraportti 27.5. | ||
2025 Q4 -tulosraportti 27.2. | ||
2025 Q3 -tulosraportti 27.11.2025 | ||
2025 Q2 -tulosraportti 27.8.2025 |
Foorumi
Liity keskusteluun Nordnet Socialissa
Kirjaudu
- 16 min sitten · MuokattuThe company valuation slumped at levels last seen in 2024 and meanwhile people still can’t admit they were so incredibly delusional that they actually believed some life saving deal was just around the corner. Hilarious. Face facts, I was correct ever since the initial down trend from 11SEK. The burn rate is far too high to be headed anywhere else than refinancing on dilutive terms or a straight up FPO. Furthermore no data, not even the latest EAP data have concrete signs of efficacy so that big licensing deal/exit everyone was convinced was going to happen isn’t anywhere close to being closed on. Hyperoptimists 0 - Realists 1
- ·2 päivää sittenNot easy to interpret today's report? But more money will be needed in 6 months - again!? After just received 60 million!? Burn rate of 10 million a month!! Hmmm…. One probably needs to ponder a bit here.Acceleron had a market cap of approximately $2bn before the phase 2 results, just over ten times higher than Cereno has after its phase 2a. For those who believe that Cereno can deliver placebo-controlled results in line with Acceleron's PULSAR, Cereno is a bargain. Even though I have some hope for the therapy itself, I have long since lost confidence in Cereno as a company. They have promised much but delivered little. The expected positive announcements over the past year have, without exception, been disappointments. Possibly, possibly they can turn it around, but before anything positive comes, I expect a continued downward trend. If I invest, I will do so when more clarity is available regarding the ongoing phase 2 study.
- ·19.8.I've been well over 100% up, now I'm under 10%. I'm heavily invested, of course regretting not selling at the top. Now the question is? Should one sell or wait until one is left holding the bag?I sold a few months ago, only have some listening posts left. I have and had faith in the company, i.e. the product. But I've been involved since the dawn of time, I've been through the infamous spiral bank financing as well as share issues and not least when the financial supervisory authority made its entry. I eventually had a low average cost and a good number of shares, i.e. about 400k. Started selling at just over 6.5 kroner. When the sale was completed, I saw that the price was pulled down below 5, Myrild probably also sold some. So the idea was to rather chase after than lose most of it. The chase hasn't started yet. But I've taken note of what Sten has said, keep your shares, we have many stakeholders etc. Strange that this didn't affect the share price, was the fluidda study difficult or. I feel that critical questions have been shot down all the way, Sten has almost promised a deal this year, is it by the end of 2026 or from the time it was said, I hope for a deal, but I think the deal will be an insanely bad share issue. But I hope I'm wrong, after all, they have traveled the globe many times in recent years, and all meetings are fully booked but it didn't show in the share price, so I think one should also be critical and for example ask why Myrild didn't show up last time.
- 13.8.Julkaisu on poistettu.Data analysis and type of results 2028. What does the financing look like for this global study?? one might wonder?? 💭🤔
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Nordnet Socialin käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Ei dataa
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| - | - | - | - |
Huomioi, että vaikka osakkeisiin säästäminen on pitkällä aikavälillä tuottanut hyvin, tulevasta tuotosta ei ole takeita. On olemassa riski, että et saa sijoittamiasi varoja takaisin.
Välittäjätilasto
Dataa ei löytynyt